Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business & Regulation

Business & Regulation Supply Chain

Getting it Right from the Start: Simulation Optimizes Supply Chain Planning for Clinical Trials

| Benedict Hirth

Clinical supply chains are inherently dynamic and ambiguous, contributing to a high degree of uncertainty.

Business & Regulation Analytical Science

AI Reunites Pharma with Mother Nature

| Stephanie Sutton, Angus Stewart

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

Business & Regulation Profession

Growing, Adapting, Leading

| Angus Stewart, Stephanie Sutton

We interview Mary Lavin, President of Sartorius North America, about her career.

Business & Regulation Business Practice

Come Get Your Leaves

| Angus Stewart

Andes-based cannabis cultivator Clever Leaves pledges to send US$25 million of leaves to US researchers.

Business & Regulation Standards & Regulation

High Fines for High Prices

| Stephanie Sutton

Advanz Pharma is fined for substantially hiking the price of a generic drug.

Business & Regulation Standards & Regulation

The Winding Road to the Frontline for Advanced Therapies

| Angi Robinson

How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.

Business & Regulation Standards & Regulation

A Year Like No Other

| Maryam Mahdi

The EMA releases its annual report highlighting its achievements throughout 2020.

Business & Regulation Standards & Regulation

Watching the Future

| James Strachan

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

Business & Regulation Business Practice

The Digital Advantage

| Maryam Mahdi

How can pharma make the most of digital technologies?

Business & Regulation Drug Discovery

A Meeting of Mind Menders

| Angus Stewart

GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register